Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Palomar Holdings arrives at the final stretch before its November 4 results with a split narrative: analysts still broadly bullish, a bellwether firm cutting its target this week, and a stock that has clawed back 3.4% over the past week despite sitting 2.4% lower on the month.
The most immediate piece of news is JP Morgan's move on Thursday. Pablo Singzon maintained his Overweight rating but cut his price target from $167 to $156, the second time he has trimmed it this year. The stock closed Friday at $130.76, leaving around 19% of implied upside to the revised JP Morgan target. The wider analyst community has not followed suit: the consensus mean target across the coverage group is $160.17, and ratings remain firmly in positive territory across JP Morgan, Keefe Bruyette & Woods, and Piper Sandler, all of which carry Outperform or Overweight ratings. The direction of travel in targets over 2026 has been choppy. KBW and Piper raised targets aggressively through the spring, then pulled them back in May, then raised again in July. JP Morgan mirrors that arc. The net effect is a Street that is constructive on the name but unwilling to anchor on a single view ahead of the print.
The bull case rests on a margin recovery story: pricing gains flowing through to better net-to-gross earned premium ratios, loss ratios normalising from their elevated Q2 2025 levels, and EPS estimates for 2026 and 2027 that have been revised upward. The bear case centres on earthquake gross written premium growth slowing, reinsurance costs remaining a structural drag on profitability, and the risk that cat losses in any given quarter interrupt what should be a gradual improvement in the underlying loss ratio. The EV/EBIT multiple on a forward basis ranks in just the 32nd percentile of the universe, reflecting where the bear case sits in the market's mind: this is not a cheap stock on reported earnings power, and it needs the profitability narrative to hold.
Short positioning gives no additional signal here. Short interest sits at 3.2% of the free float, down 6.6% over the week after running about 10% higher on the month. That monthly build has partially unwound, leaving the position modest and directionless. Borrow costs are negligible at 0.48%, and availability is extraordinarily loose at more than 6,700%, meaning there is virtually no constraint on adding or covering shorts. The options market is equally uninspiring as a signal: the put/call ratio of 0.35 is marginally above its 20-day average of 0.34, a z-score of just 1.2, nowhere near a level that would suggest strong directional conviction from derivatives traders in either direction.
The one piece of data worth noting is a sharp spike in retail attention. Wikipedia page views and ORTEX stock page traffic combined produced a z-score of 4.4 relative to the prior 90 days, as of September 22. That is a large number for a name this size. It does not carry a measured link to Palomar's financial results, so it is colour rather than a leading indicator, but it suggests the stock has attracted more casual-investor attention than usual in recent weeks, possibly tied to hurricane season headlines and questions about cat-exposed insurers.
On the ownership side, BlackRock held 16.7% as of September 30, with a small incremental add of 16,694 shares in the period. State Street added more meaningfully, taking its position up by 60,429 shares over the same period. American Century added 181,609 shares as of September 30, one of the larger incremental moves among the top holders. On the insider side, CEO Mac Armstrong sold a combined 3,500 shares across two transactions on September 21 at prices around $134.60 to $135.57, both executed under a pre-arranged 10b5-1 plan. Planned sales carry less interpretive weight than discretionary ones, and the 90-day net insider position is negative at roughly 84,000 shares sold, though the bulk of that reflects compensation-related activity across the officer group.
With 25 days to the November 4 earnings date, the question heading into the print is whether the loss ratio trajectory has continued to improve and whether earthquake premium growth is stabilising. The last quarterly reaction was muted on the day, followed by a 6.3% decline over five sessions, so the market's patience for any miss against the recovery thesis is limited.
See the live data behind this article on ORTEX.
Open PLMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
